Picture of Sprint Bioscience AB logo

SPRINT Sprint Bioscience AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Sprint Bioscience: inhibition of autophagy with SB02024 activates immune system in tumor

Oct 27 (Reuters) - SPRINT BIOSCIENCE AB  SPRINT.ST : 
    * HAS SHOWN THAT INHIBITION OF AUTOPHAGY WITH SB02024 
ACTIVATES IMMUNE SYSTEM IN TUMOR 
 
Source text for Eikon:  ID:nWkr5sX18R  
Further company coverage:  SPRINT.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Sprint Bioscience AB

See all news